Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL)
Michael E. Rytting, Deborah A. Thomas, Susan M. O'Brien, Farhad Ravandi-Kashani, Elias J. Jabbour, Anna R. Franklin, Tapan M. Kadia, Naveen Pemmaraju, Naval G. Daver, Alessandra Ferrajoli, Guillermo Garcia-Manero, Marina Y. Konopleva, Jorge E. Cortes, Gautham Borthakur, Rebecca Garris, Maria Cardenas-Turanzas, Kurt Schroeder, Jeffrey L. Jorgensen, Steven M. Kornblau and Hagop M. Kantarjian
Article first published online: 17 JUL 2014 | DOI: 10.1002/cncr.28930
Retrospective analysis indicates that pediatric-based therapy for ALL is superior to adult-type therapy. This single institution retrospective comparison shows that the two approaches may yield similar outcomes in this patient population.